Royal Bank of Canada’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-29,400
Closed -$144K 7372
2023
Q4
$144K Sell
29,400
-70,600
-71% -$346K ﹤0.01% 5363
2023
Q3
$545K Buy
+100,000
New +$801K ﹤0.01% 3971
2023
Q2
Sell
-100,000
Closed -$822K 7503
2023
Q1
$822K Buy
+100,000
New +$1.1M ﹤0.01% 3492
2019
Q4
Sell
-200
Closed -$4K 7001
2019
Q3
$4K Sell
200
-1,100
-85% -$20.2K ﹤0.01% 6104
2019
Q2
$23K Buy
1,300
+1,000
+333% +$18K ﹤0.01% 5647
2019
Q1
$6K Hold
300
﹤0.01% 6204
2018
Q4
$5K Buy
+300
New +$4.75K ﹤0.01% 6161

Other funds holding MPT

Royal Bank of Canada's MPT Position: Q1 2026 in Review

Royal Bank of Canada increased its Medical Properties Trust (MPT) stake by 11% in Q1 2026, buying an estimated $73.2K and bringing the position to 142,647 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #3917.

Royal Bank of Canada first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.5M in Q1 2022. 493 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Royal Bank of Canada held 142,647 shares of Medical Properties Trust worth $660K as of Q1 2026.
  • Royal Bank of Canada bought 14,030 Medical Properties Trust shares in Q1 2026, an estimated $73.2K.
  • Medical Properties Trust made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3917 holding.
  • Royal Bank of Canada first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Medical Properties Trust position peaked at $30.5M in Q1 2022.
  • 493 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.